|
|
||||||||
The Journal of Immunology, Vol 155, Issue 11 5257-5267, Copyright © 1995 by American Association of Immunologists
ARTICLES |
HH Chiu, DT Crowe, ME Renz, LG Presta, S Jones, IL Weissman and S Fong
Department of Immunology, Genetech, Inc., South San Francisco, CA 94080, USA.
The integrin receptors alpha 4 beta 1 and alpha 4 beta 7 both bind to vascular cell adhesion molecule-1 (VCAM-1). Here, we report that the amino acid residue requirements for murine VCAM-1 adhesion to murine alpha 4 beta 1 (WEHI 231) and alpha 4 beta 7 (38C13/beta 7- transfectant) positive cells are strikingly similar but nonidentical under multiple adhesion activity states. By site-directed mutagenesis of domain 1 of VCAM-1, the amino acid residues on the loop between beta strands C and D (R36, Q38, I39, D40, P42) and on the adjacent antiparallel beta strand F (L70 and T72) were required for basal level adhesion to both alpha 4 beta 1-positive and alpha 4 beta 7-positive cells. Mutation at two other sites, N44 (loop between beta strands C and D) and E66 (loop between beta strands E and F), specifically reduced alpha 4 beta 7-positive cell adhesion, but not alpha 4 beta 1- positive cell adhesion. Mutation H85A augmented alpha 4 beta 7 binding but not alpha 4 beta 1 binding. These apparent differences relate to the higher intrinsic activity state of alpha 4 beta 1 on WEHI 231 than on alpha 4 beta 7 (38C13/beta 7-transfectant). In contrast, under higher adhesion activity states induced by either MnCl2 or truncation of the beta 7 cytoplasmic tail, mutation of either amino acid residue D40 or L70 completely blocked cell adhesion without evidence of structural perturbation of VCAM-1. These results suggested that the two structurally discontinuous amino acid residues, the negatively charged D40 and the hydrophobic L70 adjacently located on domain 1 of VCAM-1, are essential for interaction under multiple activity states with both alpha 4 beta 1 and alpha 4 beta 7 integrin receptors.
This article has been cited by other articles:
![]() |
S. R. Barthel, M. W. Johansson, D. M. McNamee, and D. F. Mosher Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma J. Leukoc. Biol., January 1, 2008; 83(1): 1 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Barthel, D. S. Annis, D. F. Mosher, and M. W. Johansson Differential Engagement of Modules 1 and 4 of Vascular Cell Adhesion Molecule-1 (CD106) by Integrins {alpha}4beta1 (CD49d/29) and {alpha}Mbeta2 (CD11b/18) of Eosinophils J. Biol. Chem., October 27, 2006; 281(43): 32175 - 32187. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. F. Pender, M. T. Salmela, G. Monteleone, D. Schnapp, C. McKenzie, J. Spencer, S. Fong, U. Saarialho-Kere, and T. T. MacDonald Ligation of {{alpha}}4{beta}1 Integrin on Human Intestinal Mucosal Mesenchymal Cells Selectively Up-Regulates Membrane Type-1 Matrix Metalloproteinase and Confers a Migratory Phenotype Am. J. Pathol., December 1, 2000; 157(6): 1955 - 1962. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Taraszka, J. M.G. Higgins, K. Tan, D. A. Mandelbrot, J.-h. Wang, and M. B. Brenner Molecular Basis for Leukocyte Integrin {alpha}E{beta}7 Adhesion to Epithelial (E)-Cadherin J. Exp. Med., May 1, 2000; 191(9): 1555 - 1567. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Casasnovas, C. Pieroni, and T. A. Springer Lymphocyte function-associated antigen-1 binding residues in intercellular adhesion molecule-2 (ICAM-2) and the integrin binding surface in the ICAM subfamily PNAS, March 16, 1999; 96(6): 3017 - 3022. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Newham, S. E. Craig, G. N. Seddon, N. R. Schofield, A. Rees, R. M. Edwards, E. Y. Jones, and M. J. Humphries alpha 4 Integrin Binding Interfaces on VCAM-1 and MAdCAM-1. INTEGRIN BINDING FOOTPRINTS IDENTIFY ACCESSORY BINDING SITES THAT PLAY A ROLE IN INTEGRIN SPECIFICITY J. Biol. Chem., August 1, 1997; 272(31): 19429 - 19440. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |